Clinical Trials Directory

Trials / Completed

CompletedNCT04571008

Effect of NMN Supplementation on Organ System Biology

Effect of Nicotinamide Mononucleotide (NMN) Supplementation on Organ System Biology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

The goal of this proposal is to determine whether the beneficial effects of NMN on metabolic function observed in rodents applies to people.

Detailed description

This study is looking at the effect of the dietary supplement "Nicotinamide mononucleotide" (NMN) on key cardiovascular and metabolic functions, specifically those that are important risk factors for diabetes and cardiovascular disease.

Conditions

Interventions

TypeNameDescription
OTHERPlaceboIntervention will last at least 16 weeks in the form of two capsules.
DIETARY_SUPPLEMENTTreatmentIntervention will last at least 16 weeks in the form of two or three NMN capsules (total of 300 or 450 mg/day).

Timeline

Start date
2020-10-01
Primary completion
2025-03-04
Completion
2025-03-04
First posted
2020-09-30
Last updated
2026-03-11
Results posted
2026-03-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04571008. Inclusion in this directory is not an endorsement.